Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for Chronic Knee Pain in Arthritis
NCT00211679Phase 2Unknown
- Start
- Jun 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Chronic knee pain comparing Botulinum Toxin Type A with Placebo (2 arms). Primary endpoints: Change in Pain Score at 6 months, Change in Joint Function at 6 months and 1 more. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
Chronic knee pain
Beyond the preview
Go deeper on NCT00211679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211679.